mounjaro tirzepatide weight loss Before and After Transformations Mounjaro may soon be approved

How long does it take to see results from GLOW

Your healthcare team will monitor you closely and advise you on managing these effects

Read More The US Food and Drug Administration has approved Novo Nordisks once-daily weight-loss pill, making it the first oral glucagon-like peptide 1 (GLP-1) product available for weight management

More psychiatrists will incorporate metabolic medications into their practice as the evidence base grows and as we develop better training pathways

GLP-1 receptors in the body stimulate the production of insulin and suppress the release of glucagon, a hormone that raises blood sugar levels